# Gout

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: ULORIC (febuxostat) tablets US prescribing information, section 2.1 Recommended Dosage (DailyMed SetID 54de10ef-fe5f-4930-b91d-6bbb04c664bd): "The recommended starting dosage of ULORIC is 40 mg once daily. For patients who do not achieve a serum uric acid (sUA) less than 6 mg/dL after two weeks, the recommended ULORIC dosage is 80 mg once daily." The 120 mg ceiling is from ADENURIC 120 mg film-coated tablets SmPC section 4.2 (eMC product 1925): "If serum uric acid is > 6 mg/dL ... after 2-4 weeks, ADENURIC 120 mg once daily may be considered." The US label's own ceiling is 80 mg daily. · ACR Management of Gout 2020 for the treat-to-target strategy, with the dose from Allopurinol tablets US prescribing information, section 2.3 Recommended Dosage for Gout (DailyMed SetID 211e47c6-85b9-43e8-9e07-6cc4b8f708a0): "Patients with normal kidney function: Initial dosage is 100 mg orally daily. Increase by 100 mg weekly increments until serum uric acid of 6 mg/dl or less is reached (maximum 800 mg daily)." The label's titration step is weekly against the monthly step given here. · ACR Management of Gout 2020 for the treatment strategy, with the acute regimen from Colchicine 500 microgram tablets SmPC section 4.2 (eMC product 100968): "Treatment of acute gout attack: 1 mg (2 tablets) to start followed by 500 micrograms (1 tablet)" an hour later, then "No further tablets should be taken for 12 hours." The SmPC allows the course to resume after that, ending "when symptoms are relieved or when a total of 6 mg (12 tablets) has been taken", above the 1.5 mg per course given here. · ACR Management of Gout 2020 · Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560) · Ibuprofen 400 mg film-coated tablets (POM) SmPC section 4.2 (eMC product 7020)
- Verified date: 2026-08

## Verified against

- ULORIC (febuxostat) tablets US prescribing information, section 2.1 Recommended Dosage (DailyMed SetID 54de10ef-fe5f-4930-b91d-6bbb04c664bd): "The recommended starting dosage of ULORIC is 40 mg once daily. For patients who do not achieve a serum uric acid (sUA) less than 6 mg/dL after two weeks, the recommended ULORIC dosage is 80 mg once daily." The 120 mg ceiling is from ADENURIC 120 mg film-coated tablets SmPC section 4.2 (eMC product 1925): "If serum uric acid is > 6 mg/dL ... after 2-4 weeks, ADENURIC 120 mg once daily may be considered." The US label's own ceiling is 80 mg daily.
- ACR Management of Gout 2020 for the treat-to-target strategy, with the dose from Allopurinol tablets US prescribing information, section 2.3 Recommended Dosage for Gout (DailyMed SetID 211e47c6-85b9-43e8-9e07-6cc4b8f708a0): "Patients with normal kidney function: Initial dosage is 100 mg orally daily. Increase by 100 mg weekly increments until serum uric acid of 6 mg/dl or less is reached (maximum 800 mg daily)." The label's titration step is weekly against the monthly step given here.
- ACR Management of Gout 2020 for the treatment strategy, with the acute regimen from Colchicine 500 microgram tablets SmPC section 4.2 (eMC product 100968): "Treatment of acute gout attack: 1 mg (2 tablets) to start followed by 500 micrograms (1 tablet)" an hour later, then "No further tablets should be taken for 12 hours." The SmPC allows the course to resume after that, ending "when symptoms are relieved or when a total of 6 mg (12 tablets) has been taken", above the 1.5 mg per course given here.
- ACR Management of Gout 2020
- Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560)
- Ibuprofen 400 mg film-coated tablets (POM) SmPC section 4.2 (eMC product 7020)
- Gout - disease-level clinical article (gout-clinical.txt)
- Egyptian National Drug Formulary (endf-endocrine.txt)

## Treatment metadata

- Colchicine — 0.5 mg — oral.solid
- Ibuprofen — 400 mg — oral.solid
- Referral & safety-netting (no drug therapy)
- Prednisolone — 5 mg — oral.solid
- Allopurinol — 100 mg — oral.solid
- Febuxostat — 80 mg — oral.solid

## Complete treatment card

```text
GOUT
Sources: ULORIC (febuxostat) tablets US prescribing information, section 2.1 Recommended Dosage
         (DailyMed SetID 54de10ef-fe5f-4930-b91d-6bbb04c664bd): "The recommended starting dosage of
         ULORIC is 40 mg once daily. For patients who do not achieve a serum uric acid (sUA) less
         than 6 mg/dL after two weeks, the recommended ULORIC dosage is 80 mg once daily." The 120
         mg ceiling is from ADENURIC 120 mg film-coated tablets SmPC section 4.2 (eMC product 1925):
         "If serum uric acid is > 6 mg/dL ... after 2-4 weeks, ADENURIC 120 mg once daily may be
         considered." The US label's own ceiling is 80 mg daily. · ACR Management of Gout 2020 for
         the treat-to-target strategy, with the dose from Allopurinol tablets US prescribing
         information, section 2.3 Recommended Dosage for Gout (DailyMed SetID
         211e47c6-85b9-43e8-9e07-6cc4b8f708a0): "Patients with normal kidney function: Initial
         dosage is 100 mg orally daily. Increase by 100 mg weekly increments until serum uric acid
         of 6 mg/dl or less is reached (maximum 800 mg daily)." The label's titration step is weekly
         against the monthly step given here. · ACR Management of Gout 2020 for the treatment
         strategy, with the acute regimen from Colchicine 500 microgram tablets SmPC section 4.2
         (eMC product 100968): "Treatment of acute gout attack: 1 mg (2 tablets) to start followed
         by 500 micrograms (1 tablet)" an hour later, then "No further tablets should be taken for
         12 hours." The SmPC allows the course to resume after that, ending "when symptoms are
         relieved or when a total of 6 mg (12 tablets) has been taken", above the 1.5 mg per course
         given here. · ACR Management of Gout 2020 · Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC
         product 4560) · Ibuprofen 400 mg film-coated tablets (POM) SmPC section 4.2 (eMC product
         7020)
Review status: REVIEWED against ULORIC (febuxostat) tablets US prescribing information, section 2.1
               Recommended Dosage (DailyMed SetID 54de10ef-
               fe5f-4930-b91d-6bbb04c664bd): "The recommended starting dosage of
               ULORIC is 40 mg once daily. For patients who do not achieve a serum
               uric acid (sUA) less than 6 mg/dL after two weeks, the recommended
               ULORIC dosage is 80 mg once daily." The 120 mg ceiling is from
               ADENURIC 120 mg film-coated tablets SmPC section 4.2 (eMC product
               1925): "If serum uric acid is > 6 mg/dL ... after 2-4 weeks,
               ADENURIC 120 mg once daily may be considered." The US label's own
               ceiling is 80 mg daily., ACR Management of Gout 2020 for the treat-
               to-target strategy, with the dose from Allopurinol tablets US
               prescribing information, section 2.3 Recommended Dosage for Gout
               (DailyMed SetID 211e47c6-85b9-43e8-9e07-6cc4b8f708a0): "Patients
               with normal kidney function: Initial dosage is 100 mg orally daily.
               Increase by 100 mg weekly increments until serum uric acid of 6
               mg/dl or less is reached (maximum 800 mg daily)." The label's
               titration step is weekly against the monthly step given here., ACR
               Management of Gout 2020 for the treatment strategy, with the acute
               regimen from Colchicine 500 microgram tablets SmPC section 4.2 (eMC
               product 100968): "Treatment of acute gout attack: 1 mg (2 tablets)
               to start followed by 500 micrograms (1 tablet)" an hour later, then
               "No further tablets should be taken for 12 hours." The SmPC allows
               the course to resume after that, ending "when symptoms are relieved
               or when a total of 6 mg (12 tablets) has been taken", above the 1.5
               mg per course given here., ACR Management of Gout 2020, Ibuprofen
               100 mg/5 ml SmPC section 4.2 (eMC product 4560), Ibuprofen 400 mg
               film-coated tablets (POM) SmPC section 4.2 (eMC product 7020), Gout
               - disease-level clinical article (gout-clinical.txt), Egyptian
               National Drug Formulary (endf-endocrine.txt)  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (6)
    - An acute flare starts abruptly with severe pain, redness, and swelling that peaks within 12 to
      24 hours, almost always in one joint  [redness]
    - The big toe joint is involved in about half of first attacks, and nearly 90% of patients
      eventually develop it there
    - Flares are commonly triggered by trauma, alcohol binges, fasting or overeating, weight
      changes, diuretics, or starting urate-lowering therapy  [overeating]
    - Flares tend to strike at night or in the early morning, often waking the patient from sleep
    - About 60% of patients have a second attack within a year, and 80% within three years
    - Tophi typically take ten years or more to develop after the first gout attack, though
      microtophi may form earlier
  SIGNS - what you find (4)
    - The joint is warm, red, and swollen and is extremely tender to touch; more than four joints
      involved is termed polyarticular gout
    - Inflammation can extend beyond the joint, resembling cellulitis with redness and skin peeling
      [cellulitis · redness]
    - Tophi cluster mainly around the ears, finger pads, tendons, bursae, and joints
    - Finger pad tophi occur in about 30% of chronic tophaceous gout and may appear before an attack
      in postmenopausal women with kidney disease
  TESTS (6)
    - Finding needle-shaped urate crystals in joint fluid under polarized light microscopy is the
      gold-standard test
    - In septic arthritis the joint fluid white cell count typically runs over 50,000 per
      microliter, mostly neutrophils
    - The best time to check baseline serum urate is two weeks or more after a flare has settled
    - A uric acid level above 6.8 mg/dL supports the diagnosis but is not required or sufficient on
      its own
    - X-rays of an affected joint can show punched-out, rat-bite-type erosions with thin overhanging
      edges
    - Ultrasound's double-contour sign is about 83% sensitive and 76% specific, while dual-energy CT
      is about 87% sensitive and 84% specific
  IF NOT THIS - what else fits (4)
    - Septic arthritis shows a positive synovial gram stain and culture with low synovial glucose,
      and can coexist with gout
    - Rheumatoid arthritis enters the differential for tophaceous gout mainly when rheumatoid
      nodules are present
    - Pseudogout, caused by calcium pyrophosphate crystals rather than urate, is distinguished by
      joint fluid analysis
    - Osteoarthritis and psoriatic arthritis are both on the differential for an acute gout flare
  Source  StatPearls "Gout" - disease-level clinical article
  Status  traced to the source above

1. COLCHICINE                                             [1st line]
   Adult    1 mg initially, then 0.5 mg 1h later (max 1.5 mg per course) x 3 days
   Peds     Specialist use only in children
   Source   ACR Management of Gout 2020 for the treatment strategy, with the acute regimen from
            Colchicine 500 microgram tablets SmPC section 4.2 (eMC product 100968): "Treatment of
            acute gout attack: 1 mg (2 tablets) to start followed by 500 micrograms (1 tablet)" an
            hour later, then "No further tablets should be taken for 12 hours." The SmPC allows the
            course to resume after that, ending "when symptoms are relieved or when a total of 6 mg
            (12 tablets) has been taken", above the 1.5 mg per course given here.
   Why      Anti-inflammatory that inhibits neutrophil migration and activation by disrupting
            microtubule assembly, used for rapid control of an acute gout flare; its narrow
            therapeutic index means the recommended course must not be exceeded.
   Caution  Diarrhoea or vomiting signals toxicity - stop immediately.
            Reduce dose in renal impairment; avoid with strong CYP3A4 inhibitors.
            Colchicine has a narrow therapeutic index, so do not exceed the recommended dose.
   Egypt    COLCHICINE 500 MCG 100 TABS.     EL NASR            190.00 EGP (1.90/unit)
            COLMEDITEN 0.5 MG 100 TABS.      KAHIRA             190.00 EGP (1.90/unit)
            GOURYST 0.5 MG 100 TABS.         PHAROPHARMA        190.00 EGP (1.90/unit)

2. IBUPROFEN                                              [1st line]
   Adult    400-800 mg TID with food for acute gout flare x 5-7 days
   Peds     Specialist use only for pediatric arthritis
   Choice   Alternatives. An NSAID, colchicine and a steroid are co-equal for an acute gout flare;
            ibuprofen costs 4-78 EGP against colchicine's 190, and colchicine's dosing is easy to
            get wrong.
   Source   Ibuprofen 400 mg film-coated tablets (POM) SmPC section 4.2 (eMC product 7020)
   Why      NSAID that reduces the inflammatory response of an acute gout flare through cyclo-
            oxygenase inhibition; an alternative to colchicine for patients without
            contraindications such as peptic ulcer disease or significant renal impairment.
   Caution  Avoid in peptic ulcer disease, severe heart failure, or CKD.
            Take with meals or gastroprotection.
            Discontinue when acute flare resolves.
            Contraindicated in third trimester of pregnancy (risk of premature closure of fetal
            ductus arteriosus).
            Above 1200 mg a day is prescription territory, not the over-the-counter suspension. The
            tablet label allows up to 2400 mg in three or four divided doses, but only as a
            temporary increase in an acute severe episode, and no single dose above 800 mg.
   Egypt    DAJUANOFEN 400 MG 20 F.C. TABS.  COPAD PHARMA         5.00 EGP (0.25/unit)
            FLABU 400MG 10 F.C.TAB.          DELTA PHARMA         3.75 EGP (0.38/unit)
            NOVA-PROFEN 400MG 30 F.C. TABLETS SANOFI                           12.75 EGP (0.42/unit)
            IBUPROFEN 400 MG 10 TAB.         SEDICO               6.00 EGP (0.60/unit)
            MAFO 400 MG  30 F.C.TABS         EIPICO              42.00 EGP (1.40/unit)
            BRUFEN 400 MG 30 TABS.           KAHIRA > ABBO...    78.00 EGP (2.60/unit)
            PROFUSOL 400MG 20 S.G CAPS.      EUROPEAN EGYP...    31.00 EGP
            ANALGIPROF 400 MG 25 SACHETS     EVA PHARMA          37.50 EGP
            NOVA-PROFEN  100MG/5ML ORAL SUSP. 100ML SANOFI                                  2.25 EGP
                -> ? strength differs, ? different route - not oral solid
            BRUFEMOL-N SUSP. 60 ML           ARAB DRUG COM...     4.50 EGP
                -> ? strength differs, ? different route - not oral solid

3. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)            [1st line]
   Adult    
   Source   Gout - disease-level clinical article (gout-clinical.txt)
   Why      Carries the referral criteria and warning signs for this condition, which apply
            whichever treatment is chosen.
   Caution  RED FLAG - The criteria for rheumatology referral are unclear etiology, renal impairment
            limiting drug choice, inadequate response to a xanthine oxidase inhibitor, multiple
            intolerances, and refractory or tophaceous gout.
            RED FLAG - Septic arthritis needs to be excluded (arthrocentesis or synovial fluid
            analysis) before presumptively treating an unclear acute flare, since oral or intra-
            articular glucocorticoids can worsen undiagnosed septic arthritis.

4. PREDNISOLONE                                           [1st line]
   Adult    5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses. x 5 to 10 days
   Peds     0.1-2 mg/kg/day
            (Children: 0.1 to 2 mg/kg/day orally in 1 to 4 divided doses.)
            3kg -> 0.3-6 mg/day    4kg -> 0.4-8 mg/day    5kg -> 0.5-10 mg/day
            6kg -> 0.6-12 mg/day   7kg -> 0.7-14 mg/day   8kg -> 0.8-16 mg/day
            9kg -> 0.9-18 mg/day   10kg -> 1-20 mg/day    11kg -> 1.1-22 mg/day
            12kg -> 1.2-24 mg/day  13kg -> 1.3-26 mg/day  14kg -> 1.4-28 mg/day
            15kg -> 1.5-30 mg/day  16kg -> 1.6-32 mg/day  17kg -> 1.7-34 mg/day
            18kg -> 1.8-36 mg/day  19kg -> 1.9-38 mg/day  20kg -> 2-40 mg/day
            21kg -> 2.1-42 mg/day  22kg -> 2.2-44 mg/day  23kg -> 2.3-46 mg/day
            24kg -> 2.4-48 mg/day  25kg -> 2.5-50 mg/day  26kg -> 2.6-52 mg/day
            27kg -> 2.7-54 mg/day  28kg -> 2.8-56 mg/day  29kg -> 2.9-58 mg/day
            30kg -> 3-60 mg/day    31kg -> 3.1-62 mg/day  32kg -> 3.2-64 mg/day
            33kg -> 3.3-66 mg/day  34kg -> 3.4-68 mg/day  35kg -> 3.5-70 mg/day
            36kg -> 3.6-72 mg/day  37kg -> 3.7-74 mg/day  38kg -> 3.8-76 mg/day
            39kg -> 3.9-78 mg/day  40kg -> 4-80 mg/day    41kg -> 4.1-82 mg/day
            42kg -> 4.2-84 mg/day  43kg -> 4.3-86 mg/day  44kg -> 4.4-88 mg/day
            45kg -> 4.5-90 mg/day  46kg -> 4.6-92 mg/day  47kg -> 4.7-94 mg/day
            48kg -> 4.8-96 mg/day  49kg -> 4.9-98 mg/day  50kg -> 5-100 mg/day
   Source   Egyptian National Drug Formulary (endf-endocrine.txt)
   Why      Systemic glucocorticoid used as first-line anti-inflammatory treatment for acute gout
            flares, particularly when NSAIDs or colchicine are contraindicated.
   Caution  Use with caution in patients with diabetes mellitus, hypertension, osteoporosis, or
            active infection.
            Abrupt withdrawal after prolonged use may cause adrenal insufficiency.
   Egypt    HOSTACORTIN H 5MG 30 TAB.        SANOFI              12.00 EGP (0.40/unit)
            PREDNISOLONE 5 MG 20 TABS.       ARAB DRUG COM...    24.00 EGP (1.20/unit)
            PREDILONE 5MG 10 TAB. (25 STRIPS PACK) KAHIRA                    250.00 EGP (25.00/unit)
            EPICOPRED 5 MG 30 ORODISPERSIBLE TABS. EIPICO                                  69.00 EGP
            PREDNISOLONE-EVA 5 MG 30 ORODISPERSIBLE TABS. EVA PHARMA                       79.50 EGP
            DISPRELONE-OD 5 MG 30 ORODISPERSABLE TABS. ANDALOUS PHARMA                     84.00 EGP
            SOLUPRED ORO 5 MG 30 ORODISPERSIBLE TABS. SANOFI WINTHROP > SANOFI             84.00 EGP
            ACETASEE 1% EYE DROPS (SUSP.) 5 ML RAMEDA                                       7.50 EGP
                -> ? strength differs, ? different route - not oral solid
            PREDNIS 5MG/5ML SYRUP 100 ML     PHAROPHARMA          9.50 EGP
                -> ? strength differs, ? different route - not oral solid

5. ALLOPURINOL                                            [2nd line]
   Adult    100 mg once daily, titrate by 100 mg monthly to target urate <6 mg/dL - long-term
   Peds     Specialist use in pediatric hyperuricemia
   Choice   Alternatives. Allopurinol is the first-line urate-lowering agent and the cheaper (6-39
            EGP against 64-147); febuxostat is for when allopurinol cannot be used.
   Source   ACR Management of Gout 2020 for the treat-to-target strategy, with the dose from
            Allopurinol tablets US prescribing information, section 2.3 Recommended Dosage for Gout
            (DailyMed SetID 211e47c6-85b9-43e8-9e07-6cc4b8f708a0): "Patients with normal kidney
            function: Initial dosage is 100 mg orally daily. Increase by 100 mg weekly increments
            until serum uric acid of 6 mg/dl or less is reached (maximum 800 mg daily)." The label's
            titration step is weekly against the monthly step given here.
   Why      Xanthine oxidase inhibitor that lowers serum urate to prevent future flares and tophus
            formation; first-line long-term urate-lowering therapy, started only once the acute
            flare has settled and with flare prophylaxis co-prescribed.
   Caution  Do NOT start during acute flare; co-prescribe colchicine/NSAID prophylaxis.
            Dose adjustment is mandatory in renal impairment.
            There is a risk of severe cutaneous adverse reactions (SCAR).
   Egypt    NO-URIC 100 MG 50 TABS.          EIPICO              12.00 EGP (0.24/unit)
            URIC PURE 100MG 50 TAB.          MEPACO              13.50 EGP (0.27/unit)
            LESSURIC 100MG 20 TAB.           ALEXANDRIA           6.00 EGP (0.30/unit)
            ZYLORIC 100 MG 30 TABS.          GLAXO SMITHKL...    39.00 EGP (1.30/unit)

6. FEBUXOSTAT                                             [2nd line]
   Adult    40 mg once daily, increase to 80 mg once daily if urate >6 mg/dL after 2-4 weeks (max
            120 mg daily) - long-term
   Peds     Not recommended in children
   Source   ULORIC (febuxostat) tablets US prescribing information, section 2.1 Recommended Dosage
            (DailyMed SetID 54de10ef-fe5f-4930-b91d-6bbb04c664bd): "The recommended starting dosage
            of ULORIC is 40 mg once daily. For patients who do not achieve a serum uric acid (sUA)
            less than 6 mg/dL after two weeks, the recommended ULORIC dosage is 80 mg once daily."
            The 120 mg ceiling is from ADENURIC 120 mg film-coated tablets SmPC section 4.2 (eMC
            product 1925): "If serum uric acid is > 6 mg/dL ... after 2-4 weeks, ADENURIC 120 mg
            once daily may be considered." The US label's own ceiling is 80 mg daily.
   Why      Alternative xanthine oxidase inhibitor for urate-lowering when allopurinol cannot be
            used or is not tolerated; reserved for patients without established cardiovascular
            disease given its cardiovascular safety signal relative to allopurinol.
   Caution  FDA warning: there is an increased risk of cardiovascular death versus allopurinol.
            Avoid in established CV disease unless allopurinol intolerant.
            Monitor liver enzymes baseline and periodically.
   Egypt    EFFECTURIN 80 MG 20 F.C. TABS.   WESTERN PHARMA      64.00 EGP (3.20/unit)
            FEBUMAGICTAM 80 MG 30 F.C. TABLETS MEDIZEN PHARMACEUTICAL IN...   105.00 EGP (3.50/unit)
            UNSIATEM 80 MG 30 TABS.          LIPTIS             114.00 EGP (3.80/unit)
            ANDOURISTAT 80 MG 20 F.C. TABLETS ANDALOUS PHARMA                  80.00 EGP (4.00/unit)
            STATURIC 80 MG 30 F.C. TABS.     MASH PREMIERE      123.00 EGP (4.10/unit)
            XANTHIBUX 80 MG 20 F.C. TABS.    MEDIZEN PHARM...    86.00 EGP (4.30/unit)
            FEBURIC 80 MG 30 F.C. TABS.      HIKMA PHARMA       139.50 EGP (4.65/unit)
            XANTHISTOP 80 MG 30 TABS.        SEDICO > INSP...   147.00 EGP (4.90/unit)

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
